RxDoctor Payments Data

Julio Santory Ortiz

General Practice · Las Piedras, PRNPI 1013979723

Payments from drug & device makers

$1,258in general payments, 2019–2025

Across 31 payments — averaging $40.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$594
  • PBG Puerto Rico LLC$119
  • E.r. Squibb & Sons, L.L.C.$117
  • Pfizer Pharmaceuticals LLC$100
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$95
  • Sanofi-aventis U.S. LLC$86
  • plus $148 from 3 others

What the payments were for

  • Food & beverage$1,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson11$594
PBG Puerto Rico LLC5$119
E.r. Squibb & Sons, L.L.C.3$117
Pfizer Pharmaceuticals LLC1$100
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$95
Sanofi-aventis U.S. LLC4$86
Inari Medical, Inc.1$69
AstraZeneca4$62
Chiesi USA, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,258 in reported general payments places this provider in the 85th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$4,614
Medicare patients
27
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$68,534
FarxigaDapagliflozin Propanediol69$62,417
Janumet XrSitagliptin Phos/Metformin Hcl53$54,835
JardianceEmpagliflozin55$49,602
TrulicityDulaglutide42$47,348
SynthroidLevothyroxine Sodium407$44,906
XareltoRivaroxaban45$42,087
JanumetSitagliptin Phos/Metformin Hcl43$34,245
TradjentaLinagliptin23$24,201
Jentadueto XrLinagliptin/Metformin Hcl34$20,009
Sucralfate168$18,402
BelsomraSuvorexant38$17,147
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid87$16,233
JanuviaSitagliptin Phosphate16$16,079
CreonLipase/Protease/Amylase15$15,183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$62$62,41769 claims
Johnson & JohnsonXarelto$594$42,08745 claims
Sanofi-aventis U.S. LLCLantus, Soliqua 100-33$86$20,473109 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Las Piedras

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →